key: cord-0742851-kkexojph
authors: Caruana, Giorgia; Lebrun, Laure-Line; Aebischer, Oriane; Opota, Onya; Urbano, Luis; de Rham, Mikael; Marchetti, Oscar; Greub, Gilbert
title: The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients
date: 2021-05-14
journal: New Microbes New Infect
DOI: 10.1016/j.nmni.2021.100899
sha: 73619d74077c040d3bb5d2492155653c63b95113
doc_id: 742851
cord_uid: kkexojph

Several reports showed SARS-CoV-2 rapid antigen tests (RATs) performances among COVID-19 symptomatic subjects in outpatient settings during periods of highest incidence of infections and high rates of hospital admissions, but few data are present for asymptomatic patients. We investigated the role of RATs in an Emergency Department, as a novel screening tool before admission for COVID-19 asymptomatic patients. A total of 116 patients were screened upon admission in a 250-bed community hospital in Morges, Switzerland. RAT detected 2/7 RT-PCR positive patients and delivered two false positive results. These data suggest the non-fiability of RATs screening in this clinical scenario.

The world has been dealing with SARS-CoV-2 pandemic since the first cases of 15 pneumonia of unknown origin described in December 2019 in Wuhan, China (1). 16 One year later, huge steps have been made in clinical knowledge on this new 17 infectious disease and different types of diagnostic tests have been developed (2). 18 Reverse transcriptase polymerase chain reaction (RT-PCR), which detects the viral 19 RNA, is now largely considered as the diagnostic gold standard. However, questions 20 remain regarding the optimal clinical use and the indications of antigen tests. 

WHO. Rolling updates on coronavirus disease